If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Luigi Mariani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Sarcoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Fenretinide Medicine & Life Sciences
Recurrence Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2018

  • 20941 Citations
  • 73 h-Index
  • 310 Article
  • 1 Comment/debate
  • 1 Letter
  • 1 Review article
2 Citations (Scopus)

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors

NEPscore Working Group, Jun 1 2018, In : Endocrine-Related Cancer. 25, 6, p. 607-618 12 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Survival
Italy
Calibration
Databases

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors

NEPscore Working Group, Jun 2018, In : Endocrine-Related Cancer. 25, 6, p. 607-618 12 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Survival
Italy
Calibration
Databases

Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration

European Association of Urology-Young Academic Urologists (EAU-YAU), Urothelial Cancer Group and the Upper Tract Urothelial Carcinoma Collaboration group, Feb 2018, In : BJU International. 121, 2, p. 252-259 8 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Carcinoma
Survival
Observation
Patient Selection

Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series

Frezza, A. M., Jones, R. L., Lo Vullo, S., Asano, N., Lucibello, F., Ben-Ami, E., Ratan, R., Teterycz, P., Boye, K., Brahmi, M., Palmerini, E., Fedenko, A., Vincenzi, B., Brunello, A., Desar, I. M. E., Benjamin, R. S., Blay, J. Y., Broto, J. M., Casali, P. G., Gelderblom, H. & 24 others, Grignani, G., Gronchi, A., Hall, K. S., Mir, O., Rutkowski, P., Wagner, A. J., Anurova, O., Collini, P., Dei Tos, A. P., Flucke, U., Hornick, J. L., Lobmaier, I., Philippe, T., Picci, P., Ranchere, D., Renne, S. L., Sbaraglia, M., Thway, K., Wagrodzki, M., Wang, W-L., Yoshida, A., Mariani, L., Kawai, A. & Stacchiotti, S., Sep 1 2018, In : JAMA oncology. 4, 9, p. 1-5 5 p.

Research output: Contribution to journalArticle

gemcitabine
Anthracyclines
Sarcoma
Disease-Free Survival
Benchmarking
5 Citations (Scopus)

Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma a multi-institutional case series

Frezza, A. M., Jones, R. L., Vullo, S. L., Asano, N., Lucibello, F., Ben-Ami, E., Ratan, R., Teterycz, P., Boye, K., Brahmi, M., Palmerini, E., Fedenko, A., Vincenzi, B., Brunello, A., Desar, I. M. E., Benjamin, R. S., Blay, J. Y., Broto, J. M., Casali, P. G., Gelderblom, H. & 24 others, Grignani, G., Gronchi, A., Hall, K. S., Mir, O., Rutkowski, P., Wagner, A. J., Anurova, O., Collini, P., Tos, A. P. D., Flucke, U., Hornick, J. L., Lobmaier, I., Philippe, T., Picci, P., Ranchere, D., Renne, S. L., Sbaraglia, M., Thway, K., Wagrodzki, M., Wang, W. L., Yoshida, A., Mariani, L., Kawai, A. & Stacchiotti, S., Sep 1 2018, In : JAMA oncology. 4, 9, e180219.

Research output: Contribution to journalArticle

gemcitabine
Anthracyclines
Sarcoma
Disease-Free Survival
Benchmarking